Adolescence and young adulthood are periods of transition when youth with DM typically experience poor outcomes. Programs that equip youth with confidence, support, and knowledge to foster successful lifelong DM management are needed. The DTP was developed to provide care and guided peer-discussions on pertinent topics with a multidisciplinary team over 4 clinic visits annually. To identify predictors for program completion, characteristics of patients who completed the program versus those who did not were examined. A total of 152 subjects were referred (prior to Covid) (53% male, 91% white, mean age at 1st visit 18.8±1.4 years, age at diagnosis 9.8±4.8 years, body mass index (BMI) %ile 74.6±20.6, HbA1c 8.9±2%, 54% on insulin pumps, 17% on continuous glucose monitors (CGM). Half (n=76) completed the program. Characteristics are presented below.

There were no differences between those that completed the program vs those that did not in depression score (measured by (PHQ-9)) (8.8±0.5 vs 8.8±0.4, p=0.87), history of visits to ED (3 vs 7%, p=0.44) or admissions (4.5 vs 7%, p=0.72) in the year prior to referral. Patients referred to the DTP appear to be a high-risk population which may explain why completion of the program was 50%. Moreover, identifying as non-white appears to be associated with non-completion of the program, emphasizing the need for different approaches to reach emerging adults.


W.Alnayem: None. J.S.Krall: Research Support; Sanofi, Becton, Dickinson and Company. L.M.Siminerio: Advisory Panel; Abbott, Research Support; Becton, Dickinson and Company, Sanofi. I.Libman: Advisory Panel; Novo Nordisk.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at